Message from the President

Striving to Realize KAITEKI
by Leveraging Our Strength
in Technology Development

Hideki Kitadai, President and CEO,

Striving to Realize KAITEKI
by Leveraging Our Strength
in Technology Development

Hideki Kitadai, President and CEO,

API Corporation was established in October 2002 as a subsidiary of two parent companies (Mitsubishi Chemical Corporation and Mitsubishi Pharma Corporation (current Mitsubishi Tanabe Pharma Corporation)) as an operating company with two main product lines: (1) healthcare products, active pharmaceutical ingredients (APIs) and intermediates, as core products, and (2) fine chemical products. In April 2014, after some organizational restructuring, Life Science Institute, Inc. has become our parent company and we are now an operating company with healthcare products as our core business.

Since foundation of the company, API Corporation has been focusing on improving its strength in technology development, production capabilities and market access. API Corporation will contribute to the improvement of people's quality of life (QOL) and realization of KAITEKI, by supplying people in Japan and around the world with healthcare products including cost-competitive high-quality pharmaceutical APIs / intermediates, and also with specialty-chemicals, including pyrithione-microbiocides and antioxidants, which were transferred in April 2021 from Mitsubishi Chemical Corporation.

Especially in healthcare products business, with the technology prowess we have developed, we are willing to provide customers services more than just contract manufacturing, and to endeavor to become CDMO (Contract Development and Manufacturing Organization) capable of proposing higher value-added production process in every step of API manufacturing including development of new synthetic routes including bio-conversion technology and improvement of production process. We are striving to further improve our bio-conversion technologies and also to expand scopes of technologies into new technologies such as continuous-flow synthesis.

In order to fulfill our corporate philosophy: “As a creative, R&D-oriented company we contribute to improvement of people's quality of life”, we will continue to carry out our corporate activities under our guiding principles of ensuring compliance, promoting environmental and safety activities, and ensuring reliable quality standards.
We ask our customers, business partners, and other parties for continued guidance and encouragement.

API Corporation

Hideki Kitadai, President and CEO,

This website uses cookies for more convenient usage and for maintaining and improving performance. Clink on "Agree" to agree and proceed, or click on "See Details" for more information and settings of cookies.